Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Aggravating Aggregators | Main | Pay-to-Delay: Not Necessarily Illegal, But Not Long For The World »

June 17, 2013

GPCRs Are As Crazy As You Thought

Email This Entry

Posted by Derek

That's my take-away from this paper, which takes a deep look at a reconstituted beta-adrenergic receptor via fluorine NMR. There are at least four distinct states (two inactive ones, the active one, and an intermediate), and the relationships between them are different with every type of ligand that comes in. Even the ones that look similar turn out to have very different thermodynamics on their way to the active state. If you're into receptor signaling, you'll want to read this one closely - and if you're not, or not up for it, just take away the idea that the landscape is not a simple one. As you'd probably already guessed.

Note: this is a multi-institution list of authors, but it did catch my eye that David Shaw of Wall Street's D. E. Shaw does make an appearance. Good to see him keeping his hand in!

Comments (6) + TrackBacks (0) | Category: Analytical Chemistry | Biological News | In Silico


COMMENTS

1. luysii on June 17, 2013 12:40 PM writes...

It is totally insane to think that a protein such as a GPCR with over 400 amino acids has just one or two conformations. What I find remarkable is that it has so few. http://luysii.wordpress.com/2010/08/04/why-should-a-protein-have-just-one-shape-or-any-shape-for-that-matter/

Permalink to Comment

2. Anonymous on June 17, 2013 1:33 PM writes...


David Shaw is actually on quite a few high-profile papers these days - see, for example:

doi: 10.1073/pnas.1218321110 (PNAS 2013)
doi: 10.1016/j.cell.2012.12.032 (Cell 2013)
doi: 10.1038/nature11701 (Nature 2012)
doi: 10.1126/science.1216533 (Science 2012)

Permalink to Comment

3. modeller on June 17, 2013 5:45 PM writes...

David Shaw isn't really "of Wall Street" anymore - his operational efforts have been primarily at DE Shaw Research for a while now, churning out Science papers with Anton the MD machine. Very cool work.

Permalink to Comment

4. barry on June 17, 2013 9:29 PM writes...

that GPCRs have relatively few accessible conformations is the least of the mystery. That the human genome preserves almost 800 of them remains to be explained. Some are important drug targets. Many of the rest seem to be olfactory. Obviously it's a neat piece of nanotechnology that has been used again and again biologically.

Permalink to Comment

5. anonymous on June 18, 2013 9:32 AM writes...

Folks from DE Shaw seem to have purely honorary authorship on this paper, seeing as it is fluorine NMR (done by Prosser's lab on samples most likely made in Kobilka's lab). There is no MD in the paper or any other obvious DE shaw contribution. Perhaps they have contributed "useful discussions" or some such thing that we, the scientists, usually claim when pressed to explain this mild form of dishonesty.

Permalink to Comment

6. A. Postdoc on June 18, 2013 12:52 PM writes...

Shaw is a crackpot billionaire who everybody sucks up to get some of his money. None of his papers/contributions to science are any better than some first year grad students JCIM paper, but because he's a billionaire he gets to publish in Cell, Nature and Science. A better example of a truly sick and stupid system couldn't be designed.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Scripps Update
What If Drug Patents Were Written Like Software Patents?
Stem Cells: The Center of "Right to Try"
Speaking of Polyphenols. . .
Dark Biology And Small Molecules
How Polyphenols Work, Perhaps?
More On Automated Medicinal Chemistry
Scripps Merging With USC?